TY - JOUR
T1 - A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay
AU - Undiagnosed Diseases Network
AU - UCLA Clinical Genomics Center
AU - Undiagnosed Diseases Network
AU - Schoch, Kelly
AU - Meng, Linyan
AU - Szelinger, Szabolcs
AU - Bearden, David R.
AU - Stray-Pedersen, Asbjorg
AU - Busk, Oyvind L.
AU - Stong, Nicholas
AU - Liston, Eriskay
AU - Cohn, Ronald D.
AU - Scaglia, Fernando
AU - Rosenfeld, Jill A.
AU - Tarpinian, Jennifer
AU - Skraban, Cara M.
AU - Deardorff, Matthew A.
AU - Friedman, Jeremy N.
AU - Akdemir, Zeynep Coban
AU - Walley, Nicole
AU - Mikati, Mohamad A.
AU - Kranz, Peter G.
AU - Jasien, Joan
AU - McConkie-Rosell, Allyn
AU - McDonald, Marie
AU - Wechsler, Stephanie Burns
AU - Freemark, Michael
AU - Kansagra, Sujay
AU - Freedman, Sharon
AU - Bali, Deeksha
AU - Millan, Francisca
AU - Bale, Sherri
AU - Nelson, Stanley F.
AU - Lee, Hane
AU - Dorrani, Naghmeh
AU - Grody, Wayne W.
AU - Lee, Hane
AU - Strom, Samuel P.
AU - Vilain, Eric
AU - Deignan, Joshua
AU - Quintero-Rivera, Fabiola
AU - Kantarci, Sibel
AU - Dorrani, Naghmeh
AU - Mullegama, Sureni
AU - Kang, Sung Hae
AU - Szelinger, Szabolcs
AU - Goldstein, David B.
AU - Xiao, Rui
AU - Yang, Yaping
AU - Posey, Jennifer E.
AU - Martinez-Agosto, Julian A.
AU - Lupski, James R.
AU - Wangler, Michael F.
N1 - Funding Information:
We are grateful to the individuals and their families who contributed to this study and allowed us to publish their information and pictures. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from molecular testing offered at the Baylor Genetics Laboratories. D.B.G. has received consultancy fees and has equity ownership in Pairnomix, LLC. S.B. is the founder and F.M. is an employee of GeneDx. J.R.L. has stock ownership in 23 and Me, is a paid consultant for Regeneron Pharmaceuticals, has stock options in Lasergen, Inc., and is a co-inventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting. This work was supported by Duke Undiagnosed Diseases Network (1U01HG007672-03 to V.S. and D.B.G.), Simons Foundation Functional Screen (368479 to M.F.W.), the National Human Genome Research Institute and National Heart Lung and Blood Institute (UM1 HG006542 to J.R.L.), Common Fund (U54NS093793 to M.F.W. and others), March of Dimes (grant# 6-FY12-324 to J.A.M.-A.), UCLA Children's Discovery Institute, UCLA CART (NIH/NICHD grant# P50-HD-055784 to J.A.M.-A.), NIH/NCATS UCLA CTSI (grant# UL1TR000124 to J.A.M.-A.), and Ting Tsung and Wei Fong Chao Foundation (to J.E.P.).
Publisher Copyright:
© 2017 American Society of Human Genetics
PY - 2017/2/2
Y1 - 2017/2/2
N2 - Whole-exome sequencing (WES) has increasingly enabled new pathogenic gene variant identification for undiagnosed neurodevelopmental disorders and provided insights into both gene function and disease biology. Here, we describe seven children with a neurodevelopmental disorder characterized by microcephaly, profound developmental delays and/or intellectual disability, cataracts, severe epilepsy including infantile spasms, irritability, failure to thrive, and stereotypic hand movements. Brain imaging in these individuals reveals delay in myelination and cerebral atrophy. We observe an identical recurrent de novo heterozygous c.892C>T (p.Arg298Trp) variant in the nucleus accumbens associated 1 (NACC1) gene in seven affected individuals. One of the seven individuals is mosaic for this variant. NACC1 encodes a transcriptional repressor implicated in gene expression and has not previously been associated with germline disorders. The probability of finding the same missense NACC1 variant by chance in 7 out of 17,228 individuals who underwent WES for diagnoses of neurodevelopmental phenotypes is extremely small and achieves genome-wide significance (p = 1.25 × 10−14). Selective constraint against missense variants in NACC1 makes this excess of an identical missense variant in all seven individuals more remarkable. Our findings are consistent with a germline recurrent mutational hotspot associated with an allele-specific neurodevelopmental phenotype in NACC1.
AB - Whole-exome sequencing (WES) has increasingly enabled new pathogenic gene variant identification for undiagnosed neurodevelopmental disorders and provided insights into both gene function and disease biology. Here, we describe seven children with a neurodevelopmental disorder characterized by microcephaly, profound developmental delays and/or intellectual disability, cataracts, severe epilepsy including infantile spasms, irritability, failure to thrive, and stereotypic hand movements. Brain imaging in these individuals reveals delay in myelination and cerebral atrophy. We observe an identical recurrent de novo heterozygous c.892C>T (p.Arg298Trp) variant in the nucleus accumbens associated 1 (NACC1) gene in seven affected individuals. One of the seven individuals is mosaic for this variant. NACC1 encodes a transcriptional repressor implicated in gene expression and has not previously been associated with germline disorders. The probability of finding the same missense NACC1 variant by chance in 7 out of 17,228 individuals who underwent WES for diagnoses of neurodevelopmental phenotypes is extremely small and achieves genome-wide significance (p = 1.25 × 10−14). Selective constraint against missense variants in NACC1 makes this excess of an identical missense variant in all seven individuals more remarkable. Our findings are consistent with a germline recurrent mutational hotspot associated with an allele-specific neurodevelopmental phenotype in NACC1.
KW - NACC1
KW - cataracts
KW - developmental/intellectual disabilities
KW - epilepsy
KW - irritability
KW - microcephaly
KW - stereotypy
KW - whole-exome sequencing
UR - http://www.scopus.com/inward/record.url?scp=85010878208&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85010878208&partnerID=8YFLogxK
U2 - 10.1016/j.ajhg.2016.12.013
DO - 10.1016/j.ajhg.2016.12.013
M3 - Article
C2 - 28132692
AN - SCOPUS:85010878208
SN - 0002-9297
VL - 100
SP - 343
EP - 351
JO - American journal of human genetics
JF - American journal of human genetics
IS - 2
ER -